1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Drug Focus NOVEMBER 2016

Autoimmune Drug Focus NOVEMBER 2016

  • November 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Blisibimod Phase III Lupus Failure A Setback But Options Remain Open
Industry Brief - DSMB Recommends Enrolment Of Second Cohort In CLBS03 Phase II Trial
Industry Brief - BD Launches Syringe Designed For Use With Humulin R U-500
Industry Trend Analysis - MannKind's Outlook Boosted By Debt Pardon
Industry Brief - CHMP Recommends Marketing Authorisation Of Novo Nordisk's Fiasp To Treat Diabetes
Industry Brief - Novo Nordisk Seeks EU Approval For Tresiba Labelling Update
Industry Brief - Pirespa Launched In Taiwan For IPF
Industry Brief - EC Approves Stelara To Treat Moderately To Severely Active CD
Industry Brief - ProMetic's PBI-4050 Phase II Trial Yields Positive Interim Data In IPF
Industry Brief - Dosing Begins In Filgotinib Phase III CD Study
Industry Trend Analysis - Teva Continues To Successfully Defend Copaxone From Generics
Industry Brief - Perrigo To Review Strategic Alternatives For Tysabri Royalty Stream
Industry Brief - Inflectra Launched In US
Industry Trend Analysis - CRL Will Delay Approval And Threatens To Frustrate Sarilumab's Competitive Advantage
Industry Trend Analysis - EC Encouraging Acceptance Of Biosimilars
Industry Brief - Baricitinib Yields Encouraging Results In RA-BEACON Phase III Trial
Industry Brief - USPTO Denies Coherus' Adalimumab Patent Review
Industry Trend Analysis - Questioning Interchangeability Will Protect Remicade Revenues
Industry Brief - Can-Fite Reaches Agreement With EMA For Advancing CF101 Phase III Psoriasis Trial
Industry Brief - Prurisol Phase IIb Trial Initiated In Moderate-To-Severe Chronic Plaque Psoriasis
Industry Brief - FDA Approves Amgen's sBLA For Expanded Use Of Enbrel To Treat Plaque Psoriasis
Industry Brief - Janssen Seeks FDA Approval For Guselkumab As Plaque Psoriasis Treatment
Industry Brief - Catalyst Gains FDA SPA Approval For Second Firdapse Phase III LEMS Trial
Industry Brief - First Patient Enrolled In Neovacs' IFNalpha Kinoid Phase IIb SLE Study
Industry Brief - Aurinia To Initiate Voclosporin Phase III LN Study
Industry Brief - Selexis/OSE Enter Service Agreements
Industry Brief - Cumberland To Acquire US Rights For Nordic's Methotrexate Injection
Industry Brief - Neovacs To Acquire IFN Alpha Manufacturing Technology From Amegabiotech
Industry Brief - Mabion Enters Biosimilar Agreement With Mylan
Industry Trend Analysis - Sandoz' Biopharmaceuticals Improving But Yet To Fulfil Potential
Industry Trend Analysis - Momenta Set To Achieve Profitability In FY17
Industry Trend Analysis - Teva's Actavis Acquisition Will Aid FY16 Revenue Jump To At Least USD21.6bn
Industry Brief - MedImmune Out-Licenses MEDI2070 Full Global Rights To Allergan
Industry Brief - Autoimmune Conferences - February 2017

Table Of Contents

Autoimmune Drug Focus NOVEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.